Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Role of Ghrelin in Cancer Cachexia

Trial Profile

The Role of Ghrelin in Cancer Cachexia

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 21 Jun 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Anamorelin (Primary)
  • Indications Cachexia; Non-small cell lung cancer
  • Focus Pharmacodynamics
  • Most Recent Events

    • 09 Aug 2016 Status changed from active, no longer recruiting to discontinued due to poor recruitment.
    • 02 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov .
    • 29 Jan 2014 Planned End Date changed from 1 Mar 2014 to 1 Mar 2016, as per ClinicalTrials.gov .
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top